208 related articles for article (PubMed ID: 11505224)
1. The -141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter region is associated with anxiolytic and antidepressive effects during treatment with dopamine antagonists in schizophrenic patients.
Suzuki A; Kondo T; Mihara K; Yasui-Furukori N; Ishida M; Furukori H; Kaneko S; Inoue Y; Otani K
Pharmacogenetics; 2001 Aug; 11(6):545-50. PubMed ID: 11505224
[TBL] [Abstract][Full Text] [Related]
2. No relationship between--141C Ins/Del polymorphism in the promoter region of dopamine D2 receptor and extrapyramidal adverse effects of selective dopamine D2 antagonists in schizophrenic patients: a preliminary study.
Mihara K; Kondo T; Suzuki A; Yasui N; Ono S; Otani K; Kaneko S
Psychiatry Res; 2001 Feb; 101(1):33-8. PubMed ID: 11223117
[TBL] [Abstract][Full Text] [Related]
3. The relationship between dopamine D2 receptor polymorphism at the Taq1 A locus and therapeutic response to nemonapride, a selective dopamine antagonist, in schizophrenic patients.
Suzuki A; Mihara K; Kondo T; Tanaka O; Nagashima U; Otani K; Kaneko S
Pharmacogenetics; 2000 Jun; 10(4):335-41. PubMed ID: 10862524
[TBL] [Abstract][Full Text] [Related]
4. Association between TaqI A dopamine D2 receptor polymorphism and therapeutic response to bromperidol: a preliminary report.
Suzuki A; Kondo T; Mihara K; Yasui-Furukori N; Otani K; Furukori H; Kaneko S; Inoue Y
Eur Arch Psychiatry Clin Neurosci; 2001; 251(2):57-9. PubMed ID: 11407439
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D2 receptor gene polymorphisms predict well the response to dopamine antagonists at therapeutic dosages in patients with schizophrenia.
Sakumoto N; Kondo T; Mihara K; Suzuki A; Yasui-Furukori N
Psychiatry Clin Neurosci; 2007 Apr; 61(2):174-80. PubMed ID: 17362435
[TBL] [Abstract][Full Text] [Related]
6. Combination of dopamine D2 receptor gene polymorphisms as a possible predictor of treatment-resistance to dopamine antagonists in schizophrenic patients.
Kondo T; Mihara K; Suzuki A; Yasui-Furukori N; Kaneko S
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep; 27(6):921-6. PubMed ID: 14499308
[TBL] [Abstract][Full Text] [Related]
7. Response to chlorpromazine treatment may be associated with polymorphisms of the DRD2 gene in Chinese schizophrenic patients.
Wu S; Xing Q; Gao R; Li X; Gu N; Feng G; He L
Neurosci Lett; 2005 Mar; 376(1):1-4. PubMed ID: 15694263
[TBL] [Abstract][Full Text] [Related]
8. Analysis of methylation and -141C Ins/Del polymorphisms of the dopamine receptor D2 gene in patients with schizophrenia.
Funahashi Y; Yoshino Y; Yamazaki K; Ozaki Y; Mori Y; Mori T; Ochi S; Iga JI; Ueno SI
Psychiatry Res; 2019 Aug; 278():135-140. PubMed ID: 31176829
[TBL] [Abstract][Full Text] [Related]
9. Functional polymorphism of -141C Ins/Del in the dopamine D2 receptor gene promoter and schizophrenia.
Ohara K; Nagai M; Tani K; Nakamura Y; Ino A; Ohara K
Psychiatry Res; 1998 Nov; 81(2):117-23. PubMed ID: 9858029
[TBL] [Abstract][Full Text] [Related]
10. The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and -141C Ins/Del polymorphisms.
Himei A; Koh J; Sakai J; Inada Y; Akabame K; Yoneda H
Psychiatry Clin Neurosci; 2002 Feb; 56(1):97-102. PubMed ID: 11929577
[TBL] [Abstract][Full Text] [Related]
11. Functional -141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter and schizophrenia in a Chinese Han population.
Xiao L; Shen T; Peng DH; Shu C; Jiang KD; Wang GH
J Int Med Res; 2013 Aug; 41(4):1171-8. PubMed ID: 23816932
[TBL] [Abstract][Full Text] [Related]
12. Dopamine D2 receptor gene -141C Insertion/Deletion polymorphism in Turkish schizophrenic patients.
Kurt H; Dikmen M; Basaran A; Yenilmez C; Ozdemir F; Degirmenci I; Gunes HV; Kucuk MU; Mutlu F
Mol Biol Rep; 2011 Feb; 38(2):1407-11. PubMed ID: 20665240
[TBL] [Abstract][Full Text] [Related]
13. No relationship between Taq1 a polymorphism of dopamine D(2) receptor gene and extrapyramidal adverse effects of selective dopamine D(2) antagonists, bromperidol, and nemonapride in schizophrenia: a preliminary study.
Mihara K; Suzuki A; Kondo T; Nagashima U; Ono S; Otani K; Kaneko S
Am J Med Genet; 2000 Jun; 96(3):422-4. PubMed ID: 10898926
[TBL] [Abstract][Full Text] [Related]
14. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia.
Arinami T; Gao M; Hamaguchi H; Toru M
Hum Mol Genet; 1997 Apr; 6(4):577-82. PubMed ID: 9097961
[TBL] [Abstract][Full Text] [Related]
15. The dopamine D2 receptor 5'-flanking variant, -141C Ins/Del, is not associated with reduced dopamine D2 receptor density in vivo.
Pohjalainen T; Någren K; Syvälahti EK; Hietala J
Pharmacogenetics; 1999 Aug; 9(4):505-9. PubMed ID: 10780270
[TBL] [Abstract][Full Text] [Related]
16. The -141C Ins/Del and Taq1A polymorphism in the dopamine D2 receptor gene may confer susceptibility to schizophrenia in Asian populations.
Wang Y; Liu L; Xin L; Fan D; Ding N; Hu Y; Cai G; Wang L; Xia Q; Li X; Yang X; Zou Y; Pan F
J Clin Neurosci; 2016 Aug; 30():1-7. PubMed ID: 27283386
[TBL] [Abstract][Full Text] [Related]
17. Prolactin response to nemonapride, a selective antagonist for D2 like dopamine receptors, in schizophrenic patients in relation to Taq1A polymorphism of DRD2 gene.
Mihara K; Kondo T; Suzuki A; Yasui N; Nagashima U; Ono S; Otani K; Kaneko S
Psychopharmacology (Berl); 2000 Apr; 149(3):246-50. PubMed ID: 10823405
[TBL] [Abstract][Full Text] [Related]
18. Sexual dysfunction in male schizophrenia: influence of antipsychotic drugs, prolactin and polymorphisms of the dopamine D2 receptor genes.
Zhang XR; Zhang ZJ; Zhu RX; Yuan YG; Jenkins TA; Reynolds GP
Pharmacogenomics; 2011 Aug; 12(8):1127-36. PubMed ID: 21749219
[TBL] [Abstract][Full Text] [Related]
19. -141C insertion/deletion polymorphism of the dopamine D2 receptor gene is associated with schizophrenia in Chinese Han population: Evidence from an ethnic group-specific meta-analysis.
Zhao X; Huang Y; Chen K; Li D; Han C; Kan Q
Asia Pac Psychiatry; 2016 Sep; 8(3):189-98. PubMed ID: 26346037
[TBL] [Abstract][Full Text] [Related]
20. D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis.
Zhang JP; Lencz T; Malhotra AK
Am J Psychiatry; 2010 Jul; 167(7):763-72. PubMed ID: 20194480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
